Recombinant Cyno u-Plasminogen Activator (uPA) Protein, CF

R&D Systems | Catalog # 11098-SE

His-tag
R&D Systems
100% Guarantee

Key Product Details

  • R&D Systems CHO-derived Recombinant Cyno u-Plasminogen Activator (uPA) Protein (11098-SE)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

CHO

Accession Number

XP_05565501.1

Applications

Enzyme Activity
View all u-Plasminogen Activator (uPA)/Urokinase Proteins and Enzymes »

Product Specifications

Source

Chinese Hamster Ovary cell line, CHO-derived cynomolgus monkey u-Plasminogen Activator (uPA)/Urokinase protein
Ser21-Leu430 with a C-terminal 10-His tag

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Lys155, Ile178, Met358

Predicted Molecular Mass

18 kDa (long A chain), 3 kDa (short A chain), 30 kDa (B chain)

SDS-PAGE

32-41 kDa (short form) and 48-59 kDa (long form), non-reducing conditions

Activity

Measured by its ability to cleave a peptide substrate, N-carbobenzyloxy-Gly-Gly-Arg-7-amido-4-methylcoumarin (Z-GGR-AMC).
The specific activity is >2000 pmol/min/μg, as measured under the described conditions.

Scientific Data Images for Recombinant Cyno u-Plasminogen Activator (uPA) Protein, CF

Recombinant Cynomolgus Monkey u‑Plasminogen Activator (uPA)/Urokinase His-tag Protein Enzyme Activity.

Recombinant Cynomolgous Monkey u-Plasminogen Activator (uPA)/Urokinase His-tag (Catalog # 11098-SE) is measured by its ability to cleave a peptide substrate, N-carbobenzyloxy-Gly-Gly-Arg-7-amido-4-methylcoumarin (Z-GGR-AMC).

Formulation, Preparation, and Storage

11098-SE
Formulation Supplied as a 0.2 μm filtered solution in HEPES, NaCl and CaCl2.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Background: u-Plasminogen Activator (uPA)/Urokinase

Urokinase Plasminogen Activator (uPA), also known as u-plasminogen activator or urokinase, is a highly-specific serine protease from the peptidase S1 family that cleaves plasminogen to form plasmin making it a key player in the plasminogen activator (PA) system (1, 2). In cancer, the PA system plays a commanding role in tumor growth, angiogenesis, tumor cell invasion, migration, and metastasis. Expression of uPA is minimal in normal cells but is increased several fold in tumor cells by extracellular stimuli elevated in cancer (3) and corresponds to poor outcomes in several types of cancer (2, 4-7). Therefore, uPA has been identified as an excellent target for therapeutic development through inhibition of protease activity or though inhibition of uPA-dependent signaling while in complex with uPA receptor (uPAR) (2, 7). The pro-enzyme of uPA is synthesized with an N-terminal signal peptide and processed into an active disulfide-linked two-chain molecule (2, 7-10). For the cynomolgous uPA, the B chain starting at Ile178 corresponds to the catalytic domain. Two forms of the A chain exist, one starting at Ser21 (the long form) and the other at Lys155 (the short form). While the B chain is common for both forms, the long and short A chains are unique to expected 48 kDa and 32 kDa two-chain forms, respectively. The long A chain contains an EGF-like domain and the kringle domain. The long A domain is reportedly responsible for the binding of the uPA receptor (uPAR) (2,7). Both high and low MW forms exist in the purified recombinant cyno uPA.

References

  1. Ellis, V. (2004) in Handbook of Proteolytic Enzymes. Barrett, A.J. et al. eds. Academic Press, San Diego, pp.1677. 
  2. Mahmood, N. et al. (2018) Front Oncol. 8:24.
  3. Nagamine, Y. et al. (2005) Thromb. Haemost. 93:661.
  4. Duffy, M. and C. Duggan (2004) Clin. Biochem. 37:541.
  5. Pappot, H. et al. (2006) Lung Cancer 51:193.
  6. Taubert, H. et al. (2010) Br. J. Cancer 102:731.
  7. Masucci, M.T. et al. (2022) Cancers. 14:498.
  8. Riccio, A. et al. (1985) Nucleic Acids Res. 13:2759.
  9. Nagai, M. et al. (1985) Gene 36:183.
  10. Jacobs, P. et al. (1985) DNA 4:139.

Long Name

Urokinase-type Plasminogen Activator

Alternate Names

PLAU, uPA, uPlasminogen Activator, Urokinase

Entrez Gene IDs

5328 (Human); 18792 (Mouse); 102135886 (Cynomolgus Monkey)

Gene Symbol

PLAU

UniProt

XP_05565501.1

Additional u-Plasminogen Activator (uPA)/Urokinase Products

Product Documents for Recombinant Cyno u-Plasminogen Activator (uPA) Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Cyno u-Plasminogen Activator (uPA) Protein, CF

For research use only

Customer Reviews for Recombinant Cyno u-Plasminogen Activator (uPA) Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Cyno u-Plasminogen Activator (uPA) Protein, CF and earn rewards!

Have you used Recombinant Cyno u-Plasminogen Activator (uPA) Protein, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for Recombinant Cyno u-Plasminogen Activator (uPA) Protein, CF (11098-SE):

Materials
  • Assay Buffer: 50 mM Tris, 0.01% (v/v) Tween® 20, pH 8.5
  • Recombinant Cynomolgus Monkey u-Plasminogen Activator (uPA)/Urokinase (rcyno uPA)  (Catalog # 11098-SE)
  • Substrate: Z-Gly-Gly-Arg-AMC (Bachem, Catalog # I-1140), 10 mM stock in DMSO
  • F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
  • Fluorescent Plate Reader (Model: SpectraMax M5 by Molecular Devices) or equivalent
  1. Dilute rcyno uPA to 1 ng/µL in Assay Buffer.
  2. Dilute Substrate to 400 µM in Assay Buffer.
  3. Load 50 μL of 1 ng/µL rcyno uPA into a black well plate, and start the reaction by adding 50 µL of 400 µM Substrate. Include a Substrate Blank containing 50 µL of Assay buffer and 50 µL of 400 µM Substrate.
  4. Read at excitation and emission wavelengths of 380 nm and 460 nm (top read), respectively, in kinetic mode for 5 minutes.
  5. Calculate specific activity:

         Specific Activity (pmol/min/µg) =

    		Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU)
    amount of enzyme (µg)
        *Adjusted for Substrate Blank
    **Derived from calibration standard 7-amino, 4-Methyl Coumarin (Sigma, Catalog # A9891)
Per Reaction:
  • rcyno uPA: 0.05 µg
  • Substrate: 200 µM

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes

Associated Pathways

Blood Coagulation Signaling Pathways Blood Coagulation Signaling Pathway Thumbnail